Pfizer Inc. stock at USD 28.73 on September 28, 2026
Published on 09/28/2026 at 22:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Pfizer Inc. stock last traded at USD 28.73 on the NYSE on September 28, 2026, according to the available market quote. The daily change was 0.21 percent.
Oncology data scheduled for ESMO
Pfizer said in a Business Wire release dated September 28, 2026, that it will present data from 45 company-sponsored, investigator-sponsored and collaborative research abstracts at the European Society for Medical Oncology Congress. The event is scheduled for October 23-27, 2026, in Madrid, Spain.
The company said the program includes 11 oral presentations covering established medicines and late-stage pipeline programs in breast, genitourinary and lung cancers. The release identified research involving products and candidates including PADCEV, TALZENNA, atirmociclib and tivunatamig.
Third-quarter results call scheduled
Pfizer also announced through Business Wire on September 22, 2026, that it will host a webcast with investment analysts at 10:00 a.m. EST on November 3, 2026. The call is intended to discuss Pfizer’s third-quarter 2026 performance report, which the company said is scheduled to be issued that morning.
